In addition, lower-level infiltrations of other types of immune cells are often observed in patients with KEAP1-mutated LUAD in the Cancer Genome Atlas (TCGA) database,28 the Tumor Immune Estimation Resource (TIMER) database,29 and the randomized phase III IMpower131 study.30 This evidence concerns the gene KEAP1 and neoplasm.